Organogenesis Holdings Inc.

NasdaqCM:ORGO Stok Raporu

Piyasa değeri: US$535.6m

Organogenesis Holdings Yönetim

Yönetim kriter kontrolleri 2/4

Organogenesis Holdings CEO'su Gary Gillheeney, Jan2014 tarihinde atandı, in görev süresi 10.83 yıldır. in toplam yıllık tazminatı $ 6.24M olup, şirket hissesi ve opsiyonları dahil olmak üzere 14.6% maaş ve 85.4% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.63% ine doğrudan sahiptir ve bu hisseler $ 3.40M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.2 yıl ve 3.8 yıldır.

Anahtar bilgiler

Gary Gillheeney

İcra Kurulu Başkanı

US$6.2m

Toplam tazminat

CEO maaş yüzdesi14.6%
CEO görev süresi10.8yrs
CEO sahipliği0.6%
Yönetim ortalama görev süresi7.2yrs
Yönetim Kurulu ortalama görev süresi3.8yrs

Son yönetim güncellemeleri

We Think Organogenesis Holdings Inc.'s (NASDAQ:ORGO) CEO Compensation Package Needs To Be Put Under A Microscope

Jun 15
We Think Organogenesis Holdings Inc.'s (NASDAQ:ORGO) CEO Compensation Package Needs To Be Put Under A Microscope

Recent updates

Organogenesis: Lurking Disruption With Recovery To Follow

Oct 15

Why Investors Shouldn't Be Surprised By Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Low P/S

Sep 09
Why Investors Shouldn't Be Surprised By Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Low P/S

We Think Organogenesis Holdings Inc.'s (NASDAQ:ORGO) CEO Compensation Package Needs To Be Put Under A Microscope

Jun 15
We Think Organogenesis Holdings Inc.'s (NASDAQ:ORGO) CEO Compensation Package Needs To Be Put Under A Microscope

Organogenesis Holdings: Small-Cap Biotech With Inconsistent Earnings And A Powerful Catalyst

Jun 10

Investors Can Find Comfort In Organogenesis Holdings' (NASDAQ:ORGO) Earnings Quality

May 21
Investors Can Find Comfort In Organogenesis Holdings' (NASDAQ:ORGO) Earnings Quality

Shareholders Should Be Pleased With Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Price

May 01
Shareholders Should Be Pleased With Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Price

Is Organogenesis Holdings (NASDAQ:ORGO) Using Too Much Debt?

Apr 10
Is Organogenesis Holdings (NASDAQ:ORGO) Using Too Much Debt?

These 4 Measures Indicate That Organogenesis Holdings (NASDAQ:ORGO) Is Using Debt Reasonably Well

Jan 04
These 4 Measures Indicate That Organogenesis Holdings (NASDAQ:ORGO) Is Using Debt Reasonably Well

Is Organogenesis Holdings (NASDAQ:ORGO) Using Too Much Debt?

May 31
Is Organogenesis Holdings (NASDAQ:ORGO) Using Too Much Debt?

Does Organogenesis Holdings (NASDAQ:ORGO) Have A Healthy Balance Sheet?

Jan 19
Does Organogenesis Holdings (NASDAQ:ORGO) Have A Healthy Balance Sheet?

Organogenesis: Finding A Spot For This Regenerative Medicines Company In My 'Bio Boom' Portfolio

Oct 18

Here's Why Organogenesis Holdings (NASDAQ:ORGO) Can Manage Its Debt Responsibly

Sep 23
Here's Why Organogenesis Holdings (NASDAQ:ORGO) Can Manage Its Debt Responsibly

Organogenesis gets FDA clearance for PuraPly MZ for wound healing

Aug 15

Here's Why Organogenesis Holdings (NASDAQ:ORGO) Has Caught The Eye Of Investors

Jul 28
Here's Why Organogenesis Holdings (NASDAQ:ORGO) Has Caught The Eye Of Investors

CEO Tazminat Analizi

Gary Gillheeney'un ücretlendirmesi Organogenesis Holdings'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$7m

Jun 30 2024n/an/a

-US$17m

Mar 31 2024n/an/a

US$6m

Dec 31 2023US$6mUS$909k

US$5m

Sep 30 2023n/an/a

US$13m

Jun 30 2023n/an/a

US$10m

Mar 31 2023n/an/a

US$13m

Dec 31 2022US$6mUS$883k

US$16m

Sep 30 2022n/an/a

US$59m

Jun 30 2022n/an/a

US$71m

Mar 31 2022n/an/a

US$83m

Dec 31 2021US$4mUS$835k

US$94m

Sep 30 2021n/an/a

US$62m

Jun 30 2021n/an/a

US$69m

Mar 31 2021n/an/a

US$43m

Dec 31 2020US$3mUS$823k

US$17m

Sep 30 2020n/an/a

-US$5m

Jun 30 2020n/an/a

-US$37m

Mar 31 2020n/an/a

-US$42m

Dec 31 2019US$1mUS$819k

-US$39m

Sep 30 2019n/an/a

-US$46m

Jun 30 2019n/an/a

-US$48m

Mar 31 2019n/an/a

-US$58m

Dec 31 2018US$3mUS$798k

-US$65m

Sep 30 2018n/an/a

-US$60m

Jun 30 2018n/an/a

-US$52m

Mar 31 2018n/an/a

-US$32m

Dec 31 2017US$1mUS$780k

-US$9m

Tazminat ve Piyasa: Gary 'nin toplam tazminatı ($USD 6.24M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 2.16M ).

Tazminat ve Kazançlar: Gary şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Gary Gillheeney (69 yo)

10.8yrs

Görev süresi

US$6,244,671

Tazminat

Mr. Gary S. Gillheeney, Sr. has been the Chief Executive Officer and President of Organogenesis Holdings Inc. since 2014 and has been its Director since December 10, 2018 & serves as its Chair of the Board...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Gary Gillheeney
President10.8yrsUS$6.24m0.63%
$ 3.4m
David Francisco
Chief Financial Officer3.8yrsUS$1.63m0.048%
$ 257.9k
Patrick Bilbo
Chief Operating Officer7.2yrsUS$2.16m0.26%
$ 1.4m
Lori Freedman
Chief Administrative & Legal Officer7.8yrsUS$1.99m0.063%
$ 339.0k
Brian Grow
Chief Commercial Officer7.2yrsUS$1.92m0.078%
$ 419.4k
William Kolb
Secretaryno dataVeri yokVeri yok
Robert Cavorsi
Vice President of Strategy3.8yrsVeri yok0.11%
$ 564.6k

7.2yrs

Ortalama Görev Süresi

57.5yo

Ortalama Yaş

Deneyimli Yönetim: ORGO 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.2 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Gary Gillheeney
President5.9yrsUS$6.24m0.63%
$ 3.4m
Glenn Nussdorf
Director21.8yrsVeri yok9.36%
$ 50.1m
Alan Ades
Director21.8yrsVeri yok8.44%
$ 45.2m
Arthur Leibowitz
Lead Independent Director5.9yrsUS$291.46k0.10%
$ 551.8k
Robert Ades
Director4yrsVeri yokVeri yok
Jon Giacomin
Independent Director3.5yrsUS$265.00k0.068%
$ 362.9k
Garrett Lustig
Directorno dataVeri yok0.021%
$ 110.4k
Michele Korfin
Independent Director2.5yrsUS$226.98k0.068%
$ 362.2k
Prathyusha Duraibabu
Independent Director3yrsUS$240.00k0.071%
$ 379.1k
David Erani
Director4yrsVeri yokVeri yok
Michael Driscoll
Independent Director2.8yrsUS$230.52kVeri yok
Gilberto Quintero
Independent Director2.5yrsUS$226.98k0.068%
$ 362.2k

3.8yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ORGO 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.8 yıldır).